Treatment of sleep disordered breathing liberates obese hypoxemic patients from oxygen
M Povitz, PJ Hanly, SR Pendharkar, MT James… - PloS one, 2015 - journals.plos.org
PloS one, 2015•journals.plos.org
Background Obese hypoxemic patients have a high prevalence of sleep disordered
breathing (SDB). It is unclear to what extent treatment of SDB can improve daytime
hypoxemia. Methods We performed a retrospective cohort study of obese hypoxemic
individuals, all of whom underwent polysomnography, arterial blood gas analysis, and
subsequent initiation of positive airway pressure (PAP) therapy for SDB. Patients were
followed for one year for change in partial pressure of arterial oxygen and the need for …
breathing (SDB). It is unclear to what extent treatment of SDB can improve daytime
hypoxemia. Methods We performed a retrospective cohort study of obese hypoxemic
individuals, all of whom underwent polysomnography, arterial blood gas analysis, and
subsequent initiation of positive airway pressure (PAP) therapy for SDB. Patients were
followed for one year for change in partial pressure of arterial oxygen and the need for …
Background
Obese hypoxemic patients have a high prevalence of sleep disordered breathing (SDB). It is unclear to what extent treatment of SDB can improve daytime hypoxemia.
Methods
We performed a retrospective cohort study of obese hypoxemic individuals, all of whom underwent polysomnography, arterial blood gas analysis, and subsequent initiation of positive airway pressure (PAP) therapy for SDB. Patients were followed for one year for change in partial pressure of arterial oxygen and the need for supplemental oxygen.
Results
One hundred and seventeen patients were treated with nocturnal PAP and had follow-up available. Adherence to PAP was satisfactory in 60%, and was associated with a significant improvement in daytime hypoxemia and hypercapnea; 56% of these patients were able to discontinue supplemental oxygen. Adherence to PAP therapy and the baseline severity of OSA predicted improvement in hypoxemia, but only adherence to PAP therapy predicted liberation from supplemental oxygen.
Conclusions
The identification and treatment of SDB in obese hypoxemic patients improves daytime hypoxemia. It is important to identify SDB in these patients, since supplemental oxygen can frequently be discontinued following treatment with PAP therapy.
PLOS以上显示的是最相近的搜索结果。 查看全部搜索结果